从进博到全球：海尔生物以科创实力定义“中国制造”新内涵

Core Insights - The high-quality development of the health industry is crucial for meeting people's needs and driving economic structural upgrades [1] - The eighth China International Import Expo (CIIE) showcased Haier Biomedical's innovations, marking a significant step in China's life sciences industry [1][2] - Haier Biomedical's breakthroughs in high-speed centrifuge technology represent a leap from dependence on foreign technology to self-reliance and global output [3][4] Technological Breakthroughs - Haier Biomedical has developed China's first 100,000 RPM ultra-speed centrifuge, breaking the long-standing international monopoly in this field [3][4] - The global market for ultra-speed centrifuges is projected to grow from $1.536 billion in 2024 to $3.276 billion by 2031, highlighting the increasing demand [3] - The company has achieved full autonomy in three core technologies: ultra-speed vacuum motors, flexible drive technology, and secondary ultra-vacuum technology [4] AI and Smart Solutions - The integration of AI in life sciences is transforming competition from equipment performance to data-driven smart ecosystem competition [6] - Haier Biomedical's smart sample management solution utilizes innovative tracking technology to enhance efficiency in sample handling [6][7] - The company's future laboratory solutions aim to create a highly efficient collaborative chain from sample preparation to result output [7] Global Expansion - Haier Biomedical's overseas revenue grew by over 30% in the first half of 2025, with a more than 200% increase in overseas market share from 2019 to 2024 [9] - The company has established localized operations in 18 countries, including the UK, the Netherlands, and the US, to better address global customer needs [9] - In Europe, Haier Biomedical's products have gained recognition, with significant installations in prestigious institutions like the British Biobank and Halle University in Germany [10] Strategic Collaborations - Haier Biomedical is collaborating with Vietnamese healthcare institutions to implement a comprehensive digital solution for medication management [11] - The company is also enhancing health capabilities in Africa through various projects, including the establishment of a full-scene laboratory for disease control [11] - These initiatives reflect Haier Biomedical's transition from a mere equipment provider to a solution-defining entity in the global market [11][12]